ipxl20150512_8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): May 12, 2015

 

 

Impax Laboratories, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-34263

 

65-0403311

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

30831 Huntwood Avenue, Hayward, CA

 

94544

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:

(510) 240-6000

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

The Company held its 2015 Annual Meeting of Stockholders on May 12, 2015. The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows:

 

Proposal 1: Election of Directors

 

Each of the following nine nominees for director was elected to serve a term of one year and until his or her successor has been elected and qualified.

 

Nominee

Votes For

Against

Abstentions

Broker Non-Votes

Leslie Z. Benet, Ph.D.

35,368,440

23,083,396

7,465

64,314,198

Robert L. Burr

33,804,229

24,642,206

12,866

64,314,198

Allen Chao, Ph.D.

41,173,550

17,277,736

8,015

64,314,198

Nigel Ten Fleming, Ph.D.

43,915,662

14,535,623

8,016

64,314,198

Larry Hsu, Ph.D.

55,679,344

2,773,748

6,209

64,314,198

Michael Markbreiter

35,440,994

23,002,490

15,817

64,314,198

Mary K. Pendergast, J.D.

46,747,409

11,701,377

10,515

64,314,198

Peter R. Terreri

44,161,963

14,282,772

14,566

64,314,198

G. Frederick Wilkinson

56,319,910

2,131,910

7,481

64,314,198

 

 

Proposal 2: Advisory Vote on Executive Compensation

 

The resolution to approve, on a non-binding advisory basis, the compensation of our named executive officers was approved.

 

Votes For

Votes Against

Abstentions

Broker Non-Votes

57,612,628

819,304

27,369

5,854,897

 

 

Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm

 

KPMG LLP was ratified as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015.

 

Votes For

Votes Against

Abstentions

Broker Non-Votes

46,795,100

17,474,014

45,084

_

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 Dated: May 13, 2015

IMPAX LABORATORIES, INC.

 

 

 

 

 

 

 

 

 

 

 

 

By:

/s/ Bryan M. Reasons

 

 

 

Name:

Bryan M. Reasons

 

 

 

Title:

Senior Vice President, Finance and Chief Financial Officer